CytomX Therapeutics, Inc. 4
4 · CytomX Therapeutics, Inc. · Filed Oct 16, 2015
Insider Transaction Report
Form 4
Kavanaugh William Michael
CSO, Head Res.&Non-Clin. Dev.
Transactions
- Award
Employee Stock Option (right to buy)
2015-05-07+246,042→ 246,042 totalExercise: $1.57Exp: 2025-02-08→ Common Stock (246,042 underlying) - Purchase
Common Stock
2015-10-14$12.00/sh+5,000$60,000→ 5,000 total - Award
Emploiyee Stock Option (right to buy)
2015-08-26+85,605→ 85,605 totalExercise: $6.61Exp: 2025-08-25→ Common Stock (85,605 underlying)
Footnotes (2)
- [F1]This option vests 25% on January 9, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day of the month.
- [F2]This option vests in 48 substantially equal monthly installments starting on August 28, 2015, with each additional installment vesting on the last day of the month.